neuromedin U-23 (Rat) [5668]
neuromedin U-23 (Rat)
| SMILES | CC(C)CC(NC(=O)C(Cc1ccccc1)NC(=O)C(Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)C(CO)NC(=O)C1CCCN1C(=O)C(C)NC(=O)C(NC(=O)C1CCCN1C(=O)CNC(=O)C(CCC(N)=O)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CCC(=O)O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)Cc1ccc(O)cc1)C(C)C)C(C)C)C(=O)NC(Cc1ccccc1)C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NC(CCCN=C(N)N)C(=O)NC(CC(N)=O)C(N)=O |
| InChIKey | YYDRKWCPVLDJJD-UHFFFAOYSA-N |
| Sequence | YKVNEYQGPVAPSGGFFLFRPRN |
| HELM | PEPTIDE1{Y.K.V.N.E.Y.Q.G.P.V.A.P.S.G.G.F.F.L.F.R.P.R.N.[am]}$$$$ |
Chemical Properties
| Hydrogen bond acceptors | None |
| Hydrogen bond donors | None |
| Rotatable bonds | None |
| Log P | -10.010 |
| Molecular weight (Da) | 2641.4 |
No bioactivity data available.
neuromedin U-23 (Rat)
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0
Database connections
|
|